1. Catalogs
  2. WISAP Medical Technology
  3. C3 Cervical Cold Coagulator

C3 Cervical Cold Coagulator

C3 Cervical Cold Coagulator

C3 Cervical Cold Coagulator

Product catalog summary
Overview
The C3 Cervical Cold Coagulator is a medical device designed for the treatment of cervical intraepithelial neoplasia (CIN), a condition often caused by chronic infection with human papillomavirus (HPV). The device is particularly suited for low-resource settings, offering a mobile and easy-to-use solution for cervical cancer prevention.

Key Features
  • No gas or autoclave required, enhancing mobility and ease of use.
  • Includes a timer function with visual and acoustic feedback for precise treatment.
  • Toggle heating for power-saving mode.
  • Heat protection to ensure patient safety.
  • Compatible with different therapy probes (flat/nipple).

Technical Specifications
  • Mains connection: 100 - 240V AC, 50/60Hz.
  • Power input: 70 VA.
  • Treatment temperature: 100°C ±10%.
  • Dimensions: 30 x 280 x 300 mm.
  • Materials: Handle made of Makrolon, thermo-probe of PPSU/VA, anti-stick coating of Teflon (FDA approved).
  • Weight: Handle - 0.2 kg, Thermo-probe - 0.1 kg.

Clinical Background
Effective treatment of CIN is crucial as many women diagnosed with cervical pre-cancer do not receive recommended treatment. The C3 device provides a clinically tested, highly efficacious, and cost-effective treatment method.

Advantages
  • Safe, fast, and efficacious prevention of cervical cancer.
  • Optimized for use in low-resource settings, independent of power grid and clinical infrastructure.
  • Designed for simple handling to maximize effect and minimize human error.

Ordering Information
The C3 set includes a handle and various therapy probes, with all sets including a power supply and adapter plug.
See more

Catalog excerpts

C3 Cervical Cold Coagulator-1

THE MOBILE SOLUTION Safe, fast and efficacious prevention of cervical cancer TIMER FUNCTION with visual and acoustic feedback TOGGLE HEATING for power saving mode C3 - Cervical Cold Coagulator Art.-No. 610x ADVANTAGES CLINICAL BACKGROUND  No gas required  Fully mobile  No autoclave required  Simple handling  Timer function  Heat protection  Different therapy probes (flat/nipple) WISAP® Medical Technology GmbH Treatment of cervical intraepithelial neoplasia (CIN) The most important cause for the development of CIN is a chronic infection with human papillomavirus (HPV). HPV is very common in the population, particularly among younger women. Regardless of screening strategy, access to effective treatment for women with cervical pre-cancer is crucial. In some countries, up to 80% of women diagnosed with cervical pre-cancer do not receive the recommended treatment. Therefore it is crucial to implement a clinically tested and highly efficacious treatment method, which is easy to handle and cheap to run. E-Mail [email protected]

 Open the catalog to page 1
C3 Cervical Cold Coagulator-2

THE MOBILE SOLUTION Safe, fast and efficacious prevention of cervical cancer Safe Heat Protection THE MOBILE SOLUTION The C3 thermo coagulator is optimized for use in lowresource settings. It is independent of power grid and clinical infrastructure, it is handheld, mobile and easy to use. This LMIC-adapted thermo coagulator is designed with one idea in mind: Simple handling for maximum effect. Therefore the device features a single optimally designed thermo-probe, together with a fixed temperature setting and a timer function. That way we eliminate any possible source for human error and ensure...

 Open the catalog to page 2

All WISAP Medical Technology catalogs and technical brochures

  1. INSUFFLATION

    12  Pages

  2. VISUALIZATION

    24  Pages

  3. Instruments

    44  Pages

  4. Morcellation

    10  Pages

  5. Gynecology

    26  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.